Log in

Fuse Science Stock Forecast, Price & News

0.00 (0.00 %)
(As of 12/4/2020 12:00 AM ET)
Today's Range
Now: $0.01
50-Day Range
MA: $0.01
52-Week Range
Now: $0.01
Volume18,106 shs
Average Volume935,214 shs
Market Capitalization$2,277.00
P/E RatioN/A
Dividend YieldN/A
Fuse Science, Inc. focuses on the development and commercialization of proprietary delivery technology for delivering energy, nutrition, and medications to humans in the United States. The company also produces and sells sports nutrition and performance products. Its products include SkyPorts, a drone support technology and energy demand network that enables long distance flight required for drone-based commerce without the need for drones to return every 15 minutes to recharge; and XTRAX, a remote monitoring system designed to measure the production of solar and other renewable energy systems, as well as transmit the data via the cellular and radio frequency, and microwave transmission network or satellite. The company was formerly known as Double Eagle Holdings, Ltd. and changed its name to Fuse Science, Inc. in December 2011. Fuse Science, Inc. was founded in 1985 and is based in Massapequa, New York.

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.00 out of 5 stars

Industry, Sector and Symbol

Industry Diagnostic substances
Current SymbolOTCMKTS:DROP



Sales & Book Value

Annual SalesN/A



Market Cap$2,277.00
Next Earnings DateN/A
OptionableNot Optionable
0.00 (0.00 %)
(As of 12/4/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive DROP News and Ratings via Email

Sign-up to receive the latest news and ratings for DROP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Fuse Science (OTCMKTS:DROP) Frequently Asked Questions

What stocks does MarketBeat like better than Fuse Science?

Wall Street analysts have given Fuse Science a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Fuse Science wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Fuse Science?

Fuse Science saw a decrease in short interest during the month of November. As of November 15th, there was short interest totaling 10,700 shares, a decrease of 44.0% from the October 31st total of 19,100 shares. Based on an average daily trading volume, of 164,900 shares, the short-interest ratio is currently 0.1 days.
View Fuse Science's Short Interest

Who are some of Fuse Science's key competitors?

What other stocks do shareholders of Fuse Science own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Fuse Science investors own include Whiting Petroleum (WLL), Omeros (OMER), Oasis Petroleum (OAS) and Chesapeake Energy (CHKAQ).

What is Fuse Science's stock symbol?

Fuse Science trades on the OTCMKTS under the ticker symbol "DROP."

How do I buy shares of Fuse Science?

Shares of DROP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Fuse Science's stock price today?

One share of DROP stock can currently be purchased for approximately $0.01.

How big of a company is Fuse Science?

Fuse Science has a market capitalization of $2,277.00.

What is Fuse Science's official website?

The official website for Fuse Science is www.poweredbyfuse.com.

How can I contact Fuse Science?

Fuse Science's mailing address is 5510 Merrick Rd, Massapequa NY, 11758. The company can be reached via phone at 516-659-7558 or via email at [email protected]

This page was last updated on 12/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.